NCT05066477View on ClinicalTrials.gov

A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 22, 2021

Primary Completion Date

June 12, 2025

Study Completion Date

June 12, 2025

Conditions
OsteopeniaOsteopenia of the Elderly
Interventions
DIETARY_SUPPLEMENT

CalGo

CalGo is a natural marine collagenic bone powder from salmon. The bone powder is a 100 % microcrystalline hydroxyapatite form of calcium and phosphorus. Furthermore it contains collagen type 2 and is enriched with vitamin D3.

OTHER

Placebo

Pure maltodextrin

Trial Locations (3)

6005

Hofseth Biocare ASA, Ålesund

6508

Kristiansund Hospital, Kristiansund

0456

Lovisenberg Diakonale Sykehus, Oslo

All Listed Sponsors
collaborator

Møre og Romsdal Hospital Trust

OTHER

lead

Hofseth Biocare ASA

INDUSTRY

NCT05066477 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Bone Mass Among Osteopenic Women | Biotech Hunter | Biotech Hunter